Related Experiment Videos
New medication treatment options for bipolar disorders
T A Ketter1, P W Wang, C Nowakowska
1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA. tketter@stanford.edu
Acta Psychiatrica Scandinavica. Supplementum
|August 28, 2004
Summary
Newer anticonvulsants and antipsychotics offer emerging treatment options for bipolar disorders and related conditions. These medications show promise for managing mania, depression, and comorbid symptoms, improving patient outcomes.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Bipolar disorder presents complex treatment challenges.
- Identifying novel therapeutic strategies is crucial for managing mood episodes and comorbidities.
Purpose of the Study:
- To evaluate emerging pharmacological treatments for bipolar disorder.
- To synthesize findings on newer anticonvulsants and antipsychotics.
Main Methods:
- Systematic review of controlled studies on new bipolar disorder treatments.
- Computerized searches and analysis of scientific meeting proceedings.
- Compilation of data categorized by drug class.
Main Results:
- Newer anticonvulsants show varied efficacy, useful for maintenance, bipolar depression, and comorbid conditions like anxiety or obesity.
- Newer antipsychotics demonstrate effectiveness in acute mania and potential for acute depression and maintenance therapy.
- Specific agents like lamotrigine, olanzapine, and quetiapine show promise for distinct aspects of bipolar disorder.
Conclusions:
- Emerging research highlights novel anticonvulsant and antipsychotic medications as valuable additions to bipolar disorder treatment.
- These newer agents offer potential benefits for managing acute episodes, long-term maintenance, and associated comorbidities.